期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021; 19 (8)
Background: This study aimed to describe the aberrations of DNA damage repair genes and other important driving genes in Chinese patients with metasta......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021; 19 (4)
Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis ......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021; 19 (4)
Background: The incidence of oral squamous cell carcinoma (OSCC) is increasing, with an estimated 369,000 new patients each year worldwide. Surgery is......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021; 19 (6)
Background: Immune-mediated diarrhea and colitis (IMDC) is a common immune-related adverse effect related to immune checkpoint inhibitors. We aimed to......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020; 18 (5)
Background: Biomarkers for chemotherapy efficacy in non-small cell lung cancer (NSCLC) are lacking. This retrospective study assesses the association ......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020; 18 (6)
Background: The role of postoperative radiotherapy (PORT) in patients with resected stage IIIA non-small cell lung cancer (NSCLC) remains controversia......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020; 18 (12)
Background: Issuing do-not-resuscitate (DNR) orders has seldom been an outcome in randomized clinical trials of advance care planning (ACP) interventi......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020; 18 (11)
Background: Head and neck adenoid cystic carcinoma (ACC) is a rare malignant tumor that is prone to local recurrence. The NCCN Guidelines for Head and......
期刊： JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020; 18 (11)
Background: Maintenance therapy with the PARP inhibitor olaparib for metastatic pancreatic cancer (M PC) with a germline BRCA1 or BRCA2 mutation has b......
